Literature DB >> 35723696

Complementary value of metabolic and tau PET imaging in the diagnosis of corticobasal degeneration.

Menglin Liang1,2, Chenhao Jia1,2, Tzu-Chen Yen3, Linwen Liu4, Mingli Li5, Ruixue Cui6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35723696     DOI： 10.1007/s00259-022-05859-w

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  10 in total

Review 1.  Corticobasal syndrome: neuroimaging and neurophysiological advances.

Authors:  F Di Stasio; A Suppa; L Marsili; N Upadhyay; F Asci; M Bologna; C Colosimo; G Fabbrini; P Pantano; A Berardelli
Journal:  Eur J Neurol       Date:  2019-03-15       Impact factor: 6.089

2.  The Imaging Features and Clinical Associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer Disease.

Authors:  Jung-Lung Hsu; Kun-Ju Lin; Ing-Tsung Hsiao; Kuo-Lun Huang; Chi-Hung Liu; Hsiu-Chuan Wu; Yi-Ching Weng; Chu-Yun Huang; Chiung-Chih Chang; Tzu-Chen Yen; Makoto Higuchi; Ming-Kuei Jang; Chin-Chang Huang
Journal:  Clin Nucl Med       Date:  2020-10       Impact factor: 7.794

3.  In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.

Authors:  Akio Kikuchi; Nobuyuki Okamura; Takafumi Hasegawa; Ryuichi Harada; Shoichi Watanuki; Yoshihito Funaki; Kotaro Hiraoka; Toru Baba; Naoto Sugeno; Ryuji Oshima; Shun Yoshida; Junpei Kobayashi; Michinori Ezura; Michiko Kobayashi; Ohito Tano; Shunji Mugikura; Ren Iwata; Aiko Ishiki; Katsutoshi Furukawa; Hiroyuki Arai; Shozo Furumoto; Manabu Tashiro; Kazuhiko Yanai; Yukitsuka Kudo; Atsushi Takeda; Masashi Aoki
Journal:  Neurology       Date:  2016-10-28       Impact factor: 9.910

4.  Corticobasal degeneration: key emerging issues.

Authors:  F Ali; K A Josephs
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

5.  Complementary Utility of Dopamine Transporter and Tau PET Imaging in the Diagnosis of Progressive Supranuclear Palsy: A Case Report.

Authors:  Chenhao Jia; Meiqi Wu; Tzu-Chen Yen; Yanfeng Li; Ruixue Cui
Journal:  Clin Nucl Med       Date:  2022-04-01       Impact factor: 7.794

Review 6.  Overview of tau PET molecular imaging.

Authors:  Gabriel Cassinelli Petersen; Michelle Roytman; Gloria C Chiang; Yi Li; Marc L Gordon; Ana M Franceschi
Journal:  Curr Opin Neurol       Date:  2022-04-01       Impact factor: 6.283

7.  Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.

Authors:  Negin Holland; Maura Malpetti; Timothy Rittman; Elijah E Mak; Luca Passamonti; Sanne S Kaalund; Frank H Hezemans; P Simon Jones; George Savulich; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Brain       Date:  2022-03-29       Impact factor: 15.255

8.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

9.  Validation of the new consensus criteria for the diagnosis of corticobasal degeneration.

Authors:  S K Alexander; T Rittman; J H Xuereb; T H Bak; J R Hodges; J B Rowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-02-12       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.